Evidence map›Paper›PMID 36557588›Full record

ArticleMicroorganisms2022

Flavacol and Its Novel Derivative 3-

Stepan Tistechok, Marc Stierhof, Anna Kachor, Maksym Myronovskyi, Oleksandr Gromyko, Andriy Luzhetskyy

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microorganisms, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Stepan TistechokDepartment of Genetics and Biotechnology, Ivan Franko National University of Lviv, 79005 Lviv, Ukraine.
Marc StierhofDepartment of Pharmaceutical Biotechnology, Saarland University, 66123 Saarbruecken, Germany.ORCID 0000-0003-2201-7420
Anna KachorDepartment of Genetics and Biotechnology, Ivan Franko National University of Lviv, 79005 Lviv, Ukraine.ORCID 0000-0002-3074-2019
Maksym MyronovskyiDepartment of Pharmaceutical Biotechnology, Saarland University, 66123 Saarbruecken, Germany.
Oleksandr GromykoDepartment of Genetics and Biotechnology, Ivan Franko National University of Lviv, 79005 Lviv, Ukraine.ORCID 0000-0002-8107-0128
Andriy LuzhetskyyDepartment of Pharmaceutical Biotechnology, Saarland University, 66123 Saarbruecken, Germany.

Funding

Ministry of Education and Science of Ukraine H/309-2003
6 · The paper itself

Abstract

Actinomycetes are one of the main producers of biologically active compounds. However, their capabilities have not been fully evaluated due to the presence of many unexpressed silent clusters; moreover, actinomycetes can probably produce new or previously discovered natural products under certain conditions. Overexpressing the

Indexed as

3-β-hydroxy flavacolAdpAflavacolsecondary metabolitesStreptomyces

Identifiers

PMID36557588
PMCPMC9783318

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.